These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9347319)

  • 1. The human 5-HT1A receptor: comparison of its binding properties in transfected cells and cortical tissue.
    Pou C; Nénonéné EK; Reader TA; Fargin A
    Gen Pharmacol; 1997 Nov; 29(5):737-47. PubMed ID: 9347319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
    Palego L; Marazziti D; Rotondo A; Batistini A; Lucacchini A; Naccarato AG; Bevilacqua G; Borsini F; Ladinsky H; Cassano GB
    Neurochem Int; 1997 Feb; 30(2):149-57. PubMed ID: 9017662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
    Nénonéné EK; Radja F; Carli M; van Gelder NM; Afkhami-Dastjerdian S; Reader TA
    Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a cloned rat serotonin 5-HT1A receptor expressed in the HeLa cell line.
    Fujiwara Y; Tomita H; Hikiji M; Kashihara K; Otsuki S; Ohnuki T; Hamagishi Y; Oki T; Sora I; Roeske WR
    Life Sci; 1993; 52(11):949-58. PubMed ID: 8095315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems.
    Schoeffter P; Bobirnac I; Boddeke E; Hoyer D
    Neuropharmacology; 1997; 36(4-5):429-37. PubMed ID: 9225266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
    Vinod KY; Subhash MN; Srinivas BN
    Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    Neurochem Res; 1997 Apr; 22(4):427-35. PubMed ID: 9130253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.